Search Thermo Fisher Scientific
Supporting faster and more informed decisions for your patients
In the rapidly advancing field of precision oncology, the growing number of targeted treatments brings new hope to your patients. However, waiting weeks for next-generation sequencing (NGS) results, and then possibly not receiving them due to quantity not sufficient (QNS) can diminish this hope. Here is what the Oncomine Dx Express Test, implemented in your pathology laboratory can enable you to do.
Make treatment decisions without waiting for delayed NGS results
Oncomine Dx Express Test delivers genomic profiles in as little as 24 hours—so you can move quickly when timing matters most.
Get results for more patients
How often are you left without answers because of the technology used? Oncomine Dx Express Test is based on amplicon NGS technology, which requires significantly less sample material than other NGS technologies.
Improve care coordination
Oncomine Dx Express Test workflow can be implemented even in smaller and NGS naïve labs, so it can be implemented also in your institution. Having the pathologists and molecular pathology experts just a phone call away and available for multi-disciplinary meetings will help to improve care for your patient. In addition, the sample will stay in-house, ready for additional tests should they be needed.
Ready to speak to a Thermo Fisher Scientific representative?
We will be happy to answer your questions about bringing NGS to your laboratory.
For In Vitro Diagnostic Use.
CN: 63025